Tyson Foods Stock Slides After Slashing Full-Year Financial Outlook

Tyson Foods (NYSE: TSN) shares fell sharply in pre-market trading after the company issued a downward revision to its fiscal 2026 financial outlook, citing significant pressure in its beef business. The stock slid 6.8% as investors reacted to the new guidance, which points to lower profitability and sales growth than previously anticipated.

Guidance Slashed

In a pre-market update, the meat processing giant announced it now expects full-year adjusted operating income to be in the range of $1.85 billion to $2.05 billion. The company also tempered its sales forecast, projecting revenue growth of only 1.5% to 2.0%.

The most significant revision came from its Beef segment, where the company now projects an operating loss between $(775) million and $(625) million. Tyson attributed the lowered guidance to significant margin compression from volatile cattle prices and the impact of lower prices on the value of its live cattle inventories.

Industry-Wide Headwinds

Ad

The company is navigating what it described as one of the most severe cattle shortages in U.S. history. CEO Donnie King stated that "the Beef pressures that have intensified this quarter reflect industry-wide cattle-cycle dynamics that required decisive action." Softer foodservice demand, driven by consumer caution on discretionary spending, has created an additional headwind.

This guidance cut follows a warning in August about deepening losses in the beef division and a subsequent announcement of the closure or sale of three beef processing facilities. These challenges are not unique to Tyson; competitor JBS also reported significant losses in its North American beef operations in the prior quarter, underscoring the sector-wide nature of the problem.

Market Reaction

Tyson's pre-market decline was a stark outlier against a modestly higher broader market, with the S&P 500 and Dow Jones Industrial Average trading in positive territory. The stock's repricing pushed its shares toward their 52-week low as investors reassessed the recovery timeline for the company's most capital-intensive segment amid persistent supply chain issues.